18,087
Total Claims
$1.0M
Drug Cost
1,258
Beneficiaries
$799
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-48%
Cost per patient vs peers
$799 vs $1,524 avg
-43%
Brand preference vs peers
7.8% vs 13.7% avg
Brand vs Generic
92% generic
Brand: 1,417 claims · $762K
Generic: 16,670 claims · $243K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rivaroxaban | 299 | $243K |
| Apixaban | 279 | $199K |
| Ticagrelor | 163 | $98K |
| Dapagliflozin Propanediol | 127 | $86K |
| Sacubitril/Valsartan | 98 | $66K |
| Omega-3 Acid Ethyl Esters | 213 | $20K |
| Evolocumab | 32 | $18K |
| Atorvastatin Calcium | 1,531 | $17K |
| Rosuvastatin Calcium | 1,368 | $17K |
| Evolocumab | 26 | $16K |
| Losartan Potassium | 1,429 | $15K |
| Metoprolol Succinate | 886 | $12K |
| Amlodipine Besylate | 1,889 | $11K |
| Irbesartan | 427 | $8,934 |
| Candesartan Cilexetil | 85 | $8,274 |
Prescribing Profile
89
Unique Drugs
$595K
Patient Profile
74
Avg Age
60%
Female
2.01
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data